This update provides insights into critical global health developments, including Merck's halt on Gardasil shipments to China ...

The company reached nearly 0.5 billion people with its medicines and vaccines in 2024, showcasing its global impact. Merck & Co Inc (NYSE:MRK) is making significant progress in its pipeline ...

In this article, we are going to take a look at where Merck & Co., Inc. (NYSE ... A report from J.P. Morgan indicated that global equities are approaching a notable period of dividend growth ...

In this article, we are going to take a look at where Merck & Co., Inc. (NYSE ... the “Oncology Pharmaceuticals Market 2024” report, global funding for cancer research has grown exponentially ...

Recent health news highlights include Gilead's upbeat 2025 forecast, Edwards Lifesciences surpassing profit estimates, New ...

This has led management to withdraw guidance for $11 billion in Gardasil annual global sales by 2030. Gardasil was 13% of Merck's sales in 2024, and roughly half of Gardasil sales tie to China.

A global pharmaceutical company partnered with DelveInsight to create a robust and simplified solution enabling its top ...

2024 Germany's Merck KGaA agreed to sell its pigments unit to China's Global New Material International (GNMI) for 665 million euros ($721.46 million), the German diversified group said on Thursday.

This post was written by Josh Lynch Shares of global pharmaceutical company Merck (NYSE:MRK) fell 11% in the morning session after the company reported mixed fourth-quarter earnings. Its full-year ...